Loomis, Sayles & Company’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-505,082
Closed -$14M 950
2017
Q4
$14M Sell
505,082
-4,660
-0.9% -$124K 0.03% 360
2017
Q3
$13.8M Buy
509,742
+74,262
+17% +$1.94M 0.03% 361
2017
Q2
$12.7M Buy
435,480
+12,474
+3% +$379K 0.03% 365
2017
Q1
$14.4M Sell
423,006
-9,518
-2% -$307K 0.04% 335
2016
Q4
$13.1M Buy
432,524
+76,206
+21% +$2.46M 0.03% 371
2016
Q3
$12.1M Sell
356,318
-8,733
-2% -$281K 0.03% 393
2016
Q2
$10.7M Buy
+365,051
New +$10.1M 0.03% 405

Other funds holding DERM

Loomis, Sayles & Company's DERM Position: Q1 2018 in Review

Loomis, Sayles & Company sold out of Dermira, Inc. (DERM) in Q1 2018, closing a stake of 505,082 shares — an estimated $14M sold.

Loomis, Sayles & Company first reported a position in DERM in Q2 2016 and held it in 7 quarters. The position peaked at $14.4M in Q1 2017. 128 funds tracked by Wall St. Rank hold DERM as of Q1 2018.

  • Loomis, Sayles & Company reported no remaining Dermira, Inc. position as of Q1 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 505,082 Dermira, Inc. shares in Q1 2018, an estimated $14M.
  • Loomis, Sayles & Company first reported a position in Dermira, Inc. in Q2 2016 and held it in 7 quarters.
  • Loomis, Sayles & Company's Dermira, Inc. position peaked at $14.4M in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2018.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.